Contact this trialFirst, we need to learn more about you.
MEDI4736 for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 3
Rockville, Maryland
This trial will study the effects of the immunotherapy drug MEDI4736 in patients with stage III unresectable NSCLC who are also receiving concurrent chemoradiation therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.